Emirates Biotech

What Emirates Biotech does

Emirates Biotech is a Dubai-headquartered biotechnology company established in July 2024 as a joint venture between S Royal Kit Emirates Investment and Global Biopolymers Industries. The company produces and markets Polylactic Acid (PLA) biopolymers under the Embio brand as plant-based, compostable alternatives to fossil-fuel-based plastics, serving converters, brand owners, and packaging manufacturers across the Middle East, Africa, and India. Emirates Biotech describes itself as the first PLA manufacturer in the Middle East & India region and is developing the Falcon PLA Project in KEZAD, Abu Dhabi — planned as the world's largest PLA production facility at 160,000 tonnes per annum across two 80,000-tonne phases, with commissioning targeted for early 2028.

The core process technology is Sulzer's licensed PLA platform covering lactide production, purification, and polymerization — proven technology already deployed at most global PLA facilities. The Embio product portfolio comprises multiple PLA grades (EB10EX, EB20EX, EB40EX, EB10MV, EB20MV, EB10HF) for rigid and flexible packaging, coated paper board, fibers, nonwovens, and 3D printing, with verified compliance to food-contact, bio-based, and compostability standards. Beyond commercial PLA, Emirates Biotech manages the polymerisation stage in the EU-funded CIRCLE consortium (€27 million, Horizon Europe, 17 partners) to convert lactic acid from food waste into high-purity PLA for automotive, cosmetics, and food packaging, and runs research partnerships with UAEU and Heriot-Watt University.

Emirates Biotech operates a B2B direct-sales model through regional Sales Development Managers covering the UAE, Oman, India, KSA, Bahrain, and Kuwait, supplemented by participation in industry trade shows (ArabPlast, Saudi Plastics & Petrochem, European Bioplastics Conference, PolyNext, Plastics Recycling Show). Embio products are distributed from local UAE inventory with smaller minimum order volumes to support regional converters and brand owners. The company is pre-revenue on the production side — the Embio range was launched in November 2025 and is in pre-marketing, while world-scale manufacturing remains under construction. Financial commitments to the Falcon PLA Project exceed USD 90 million, anchored by an equipment supply contract with Sulzer and an EPC contract with SAMSUNG E&A.

Name

Emirates Biotech

Legal name

EMIRATES BIOTECH INDUSTRIES LTD

Website

https://emiratesbiotech.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

101–250 employees

Short description

Emirates Biotech is a Dubai-based PLA biopolymer manufacturer, established in 2024 as a joint venture to produce and market plant-based, compostable plastics under the Embio brand. It serves packaging, food service, and industrial converters across the Middle East, Africa, and India, and is building the world's largest 160,000 tpa PLA facility in Abu Dhabi.

Ownership category

akta.pro rank

Product category

PLA Biopolymers / Bioplastics Manufacturing

NAICS

Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252), Plastics Packaging Film and Sheet (including Laminated) Manufacturing (326112)

SIC

Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821)

akta.pro primary industry

Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends) (IMANAAAG)

akta.pro secondary industries

Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT) (IMAEAOAA), Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films) (IMALAMAB), Compostable & Bio-Based Flexible Packaging (PLA, PHA, Cellulose Films) (IMALABAO)

Keywords

• Polylactic acid biopolymers
• PLA bioplastics manufacturing
• Compostable packaging materials
• Plant-based plastic alternatives
• Biodegradable polymer production

Headquarters

HQ city

Dubai

HQ country

United Arab Emirates

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. PLA Biopolymer Sales: Direct sales of Embio PLA biopolymers to regional converters, brand owners, and packaging manufacturers across the Middle East. Products sold with local UAE inventory for faster delivery and smaller minimum order volumes.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Emirates Biotech manufactures and sells Polylactic Acid (PLA) biopolymers under the Embio brand, marketed as plant-based, recyclable, and compostable alternatives to fossil-based plastics for rigid and flexible packaging, coated paper board, fibers, nonwovens, and 3D printing applications. Products are sold in multiple grades (EB10EX, EB20EX, EB40EX, EB10MV, EB20MV, EB10HF) with verified compliance to food-contact, bio-based, and compostability standards, and stocked locally in the UAE for regional converters, brand owners, and packaging manufacturers.

Product overview

Emirates Biotech offers a portfolio of PolyLactic Acid (PLA) biopolymers under the Embio brand, including grades EB10EX, EB20EX, EB40EX, EB10MV, EB20MV, and EB10HF for applications including rigid and flexible packaging, coated paper board, fibers, nonwovens, and 3D printing. The company's manufacturing capabilities are anchored by the Falcon PLA Project, an upcoming 160,000 tonnes per annum facility in Abu Dhabi that will be the world's largest PLA production plant when operational in 2028. Emirates Biotech also participates in the CIRCLE consortium, a European research initiative to produce PLA from food waste, demonstrating commitment to circular economy principles.

Differentiator

Problem solved

Functional benefit

Brands

• Embio: Product range of PolyLactic Acid (PLA) biopolymers designed as sustainable alternatives to traditional plastics. Includes grades for rigid and flexible packaging, coated paper board, fibers, nonwovens, and 3D printing. Launched in November 2025.

Products and services

• Embio PLA Biopolymers A line of PolyLactic Acid (PLA) biopolymers marketed under the Embio brand, offering plant-based, recyclable, and industrially compostable alternatives to fossil-based plastics. The portfolio includes grades EB10EX, EB20EX, EB40EX, EB10MV, EB20MV, and EB10HF designed for rigid and flexible packaging, coated paper board, fibers, nonwovens, and 3D printing applications, with verified compliance to food-contact, bio-based, and compostability standards. Products are stocked locally in the UAE for regional converters, brand owners, and packaging manufacturers.

Quantifiable outcome

• 160,000 tonnes per annum PLA production capacity - enough to replace approximately 3.2 billion plastic bottles
• +2 more outcomes

Segments8 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered flagship, minor and core.

• CIRCLE ConsortiumflagshipStrategic or Co-development Partner · 12 March 2026Four-year European research project funded by Horizon Europe with €27 million funding and 17 partners across the value chain. Emirates Biotech manages polymerization of lactic acid derived from food waste into high-purity PLA. Consortium includes partners such as Volkswagen, FrieslandCampina, Davines, Sulzer and Sulapac.
• Heriot-Watt UniversityminorStrategic or Co-development Partner · 17 February 2026Collaboration on HQ design competition with 17 student teams submitting proposals. Heriot-Watt University received runner-up recognition for structural framework design.
• United Arab Emirates University (UAEU)coreStrategic or Co-development Partner · 23 June 2025Strategic partnership for collaborative research on novel PLA applications and end-of-life solutions. Engages UAEU's students and faculty, leveraging university facilities to optimize PLA performance and environmental benefits.
• SAMSUNG E&AcoreImplementation/ SI/ Consulting Partner · 14 April 2025SAMSUNG E&A selected as contractor for Falcon PLA Project, overseeing all engineering, procurement, and construction work. Pre-EPC contract signed April 2025. Company has unrivalled track record in delivering complex industrial projects.
• SulzercoreTechnology or Integration · 10 December 2024Sulzer selected as technology provider for PLA production facility using their licensed PLA technology covering lactide production, purification and polymerization. Equipment supply contract signed in May 2025. Sulzer's technology is already in use at most PLA facilities worldwide.
• PESCOminorImplementation/ SI/ Consulting PartnerProject management consultant for Falcon PLA Project development and execution.
• KEZADcoreOthersKEZAD (Khalifa Economic Zones Abu Dhabi) serves as the hosting free zone for the Falcon PLA production facility in Abu Dhabi, providing infrastructure and services.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• RWDC Industries: Producer of PHA biopolymers (Solon) for food service ware, packaging, and coatings. Emerging alternative to PLA in compostable plastics end-markets targeted by Emirates Biotech.
• Danimer Scientific: US-based producer of PHA biopolymers (Nodax) for compostable packaging, food service, and coatings. Competes with PLA in the same bioplastics substitution thesis and overlapping end-markets.
• Novamont: Italian bioplastics producer (Mater-Bi starch-based and biopolyesters) competing in compostable packaging and food service ware. Adjacent technology platform but directly competes with PLA in compostable single-use applications.

Direct peers

• NatureWorks: Global leader in PLA biopolymers (Ingeo brand) and former employer of Emirates Biotech's CEO and CTO. Most directly comparable PLA producer with established grades, global customers, and world-scale manufacturing capacity.
• Futerro: Belgian PLA producer with integrated lactic acid to PLA technology. Competes in the same PLA biopolymer category as Emirates Biotech, supplying converters and brand owners across packaging and durable applications.
• TotalEnergies Corbion: Joint venture between TotalEnergies and Corbion producing Luminy PLA biopolymers. Direct global PLA competitor and former employer of Emirates Biotech's CCO; operates world-scale PLA capacity in Thailand.
• TianAn Biopolymer (Sinopec subsidiary): One of China's largest PLA producers with multi-tens-of-thousands of tonnes capacity under the Sulzer license. Competes directly with Emirates Biotech in commodity PLA supply to converters, particularly across Asia and export markets.

Others

• Sulzer: Swiss industrial engineering and licensing company supplying the proprietary PLA process technology to Emirates Biotech. Both a core technology partner and a key enabler (and indirect beneficiary) of Emirates Biotech's 160,000 tpa Falcon facility.

Regional players

• Unitika: Japanese manufacturer of PLA fibers, films, and nonwovens under the Terramac brand. Comparable PLA-based product portfolio serving packaging and fiber markets, but focused primarily on the Japanese and Asian markets rather than MEAI.

Broad incumbents

• BASF (ecovio / bioplastics): Diversified chemicals giant producing ecovio compostable bioplastics (blends including PLA). Overlaps with Emirates Biotech in compostable packaging and agricultural film end-markets, but PLA is one product line within a much broader chemicals portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/emirates-biotech

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emirates Biotech